Form 4 for HQL abrdn Life Sciences Investors
Accepted 2022-03-24 00:00:00 ET · period of report 2022-03-23 · accession 0001104659-22-037465 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-24 | 2022-03-23 | HQL | Goetz Kathleen | Dir | P - Purchase | $16.27 | +92.31 | 685.31 | +16% | +$1,502 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Shares of Beneficial Interest | 2022-03-23 | P | A | 92.31 | $16.27 | 685.31 | D | — | — |